SEC Company Response from SWISS MEDICA INC (CIK 0000318245) — Apr 14, 2005
SWISS MEDICA INC (CIK 0000318245)
Date: April 14, 2005 · CIK: 0000318245 · Accession: 0001144204-05-011393
AI Filing Summary & Sentiment
File numbers found in text: 333-122817
Letter
SWISS MEDICA, INC. 53 Yonge Street, Third Floor Toronto, Ontario, Canada M5E 1J3 (416) 362-5775 April 14, 2005 Securities and Exchange Commission VIA FACSIMILE AND EDGAR 450 Fifth Street, N.W. (202) 942-9533 Mail Stop 0405 Judiciary Plaza Washington, D.C. 20549-0405 Attn: Ms. Song P. Brandon
Re: Swiss Medica, Inc. Request for Acceleration of Registration Statement on Form SB-2 File No. 333-122817
Dear Ms. Brandon:
Swiss Medica, Inc. (the "Company") hereby requests acceleration of the effectiveness of its Registration Statement on Form SB-2 (File No. 333-122817), filed on February 14, 2005 and amended on April 6, 2005, to 5:00 p.m. on April 18, 2005, or as soon thereafter as is practicable.
The Company acknowledges the following:
(1) Should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;
(2) The action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and
(3) The Company may not assert the staff comments and the declaration of effectiveness as a defense in any proceedings initiated by the Commission or any person under the federal securities laws of the United States.
Please direct any questions or comments to Clayton E. Parker at (305) 539-3306 or Jacqueline G. Hodes at (305) 539-3387 of Kirkpatrick & Lockhart Nicholson Graham LLP, counsel to the Company.
Sincerely,
/s/ Raghunath Kilambi
---------------------------------------
Raghunath Kilambi
Chief Executive Officer
Show Raw Text
<DOCUMENT>
<TYPE>CORRESP
<SEQUENCE>1
<FILENAME>filename1.txt
<TEXT>
SWISS MEDICA, INC.
53 Yonge Street, Third Floor
Toronto, Ontario, Canada M5E 1J3
(416) 362-5775
April 14, 2005
Securities and Exchange Commission VIA FACSIMILE AND EDGAR
450 Fifth Street, N.W. (202) 942-9533
Mail Stop 0405
Judiciary Plaza
Washington, D.C. 20549-0405
Attn: Ms. Song P. Brandon
Re: Swiss Medica, Inc.
Request for Acceleration of Registration Statement on Form SB-2
File No. 333-122817
Dear Ms. Brandon:
Swiss Medica, Inc. (the "Company") hereby requests acceleration of the
effectiveness of its Registration Statement on Form SB-2 (File No. 333-122817),
filed on February 14, 2005 and amended on April 6, 2005, to 5:00 p.m. on April
18, 2005, or as soon thereafter as is practicable.
The Company acknowledges the following:
(1) Should the Commission or the staff, acting pursuant to delegated
authority, declare the filing effective, it does not foreclose the
Commission from taking any action with respect to the filing;
(2) The action of the Commission or the staff, acting pursuant to
delegated authority, in declaring the filing effective, does not
relieve the Company from its full responsibility for the adequacy
and accuracy of the disclosure in the filing; and
(3) The Company may not assert the staff comments and the declaration of
effectiveness as a defense in any proceedings initiated by the
Commission or any person under the federal securities laws of the
United States.
Please direct any questions or comments to Clayton E. Parker at (305)
539-3306 or Jacqueline G. Hodes at (305) 539-3387 of Kirkpatrick & Lockhart
Nicholson Graham LLP, counsel to the Company.
Sincerely,
/s/ Raghunath Kilambi
---------------------------------------
Raghunath Kilambi
Chief Executive Officer
</TEXT>
</DOCUMENT>